Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.
The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.
Join AHA Board Chair Melinda Estes, M.D., for the seventh in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes will joined by Jim Skogsbergh, President and CEO of Advocate…
A recent article from Axios attempts to say that the hospital and health system field is not being negatively impacted financially by the pandemic. The article ignores the diverse experiences of hospitals during the pandemic, particularly those that are under significant financial pressure.
Hospitals and health systems have reinvented themselves in many ways to respond to COVID-19. Since March, decades of standard operating procedures have been reexamined, redesigned and refined — all with the goal of saving lives while protecting caregivers and patients’ families during the pandemic.
Hospitals and health systems are protecting people, advancing access and equity, and promoting community health​. Join in us telling the story.
Medicaid enrollment for fiscal year 2021 is expected to jump 8.2%, with state spending to accelerate by 8.4%, according to data from 42 state Medicaid directors and compiled by the Kaiser Family Foundation.
The Federal Reserve will host a webinar Oct. 21 at 2 p.m. ET to help borrowers learn about the Main Street Lending Program and provide an opportunity for borrowers to get answers to specific questions on the program and its operations. Questions are to be submitted in advance to questions@askthefed…
The Department of Health and Human Services and the Department of Defense awarded $481 million to Cue Health Inc. to expand production of a point-of-care COVID-19 molecular test with capabilities to produce results in 20 minutes.
The National Institutes of Health Oct. 13 announced a study designed to identify promising COVID-19 therapies and investigational drugs that merit larger clinical trials.